BioDelivery Sciences International's investigational long-acting analgesic product, Bema LA, has performed positively in a proof-of-concept study. The active ingredient contained within Bema LA met the company's expectations in terms of the amount absorbed into the bloodstream.
Click Here to read the entire article...